GeneDx Holdings Corp. (WGS) Misses Q3 EPS by 46c

GeneDx Holdings Corp. (NASDAQ: WGS) reported Q3 EPS of ($1.64), $0.46 worse than the analyst estimate of ($1.18). Revenue for the quarter came in at $53 million versus the consensus estimate of $52.76 million.

For earnings history and earnings-related data on GeneDx Holdings Corp. (WGS) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar La
• Bernstein SocGen on Darden Restaurants (DRI): 'Story Intact'
• GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC